GUNA-TF - Cyto-Solutions Ltd

More documents

Recommendations

Info

GUNA-TF HERPESGUNA-TF HERPESCompositionTransfer Factors-HSVtype 1 and 2 at D7 potency(7X for US Physicians).IndicationsHerpes labialis and Herpes genitalisrecurrent infections; herpetickeratoconjunctivitis; herpetic-likecutaneous infections.Dosage1 capsule/day for 5 continuous days (for instance:from Monday to Friday, excluding Saturday and Sunday)for 3-4 months without break.Package sizeBottle of 20 x 230 mg capsules.Combination with other Guna medicines:· Strengthening of immune defenses in Herpes simplex I and II infections:Guna-TF Herpes + Guna-Virus
Clinical casePrevention of recurrent labialand genital herpes infectionsA clinical research study has been carried out on 44 patients, 22 affected by labial herpes and 22affected by genital herpes.All the patients have been treated for 6 continuous months with a Transfer Factor preparationobtained from in vitro culture extract of specific HSV 1 and 2 from dyalized bovine lymphocytes.In the monitoring period before the treatment (the 44 patients have been monitored globally 26.660days long) there have been 544 reacutizations with a 61.2 Relapse Index.The monitoring period during and after treatment has been of 16.945 days for the 44 patients. Inthis period there have been 121 reacutizations with a 21.4 Relapse Index.From Pizza G, Viza V, De Vinci C, Palareti AP, Cuzzocrea DE, Fornarola V & Baricordi OR. “Orally administered HSV-specifictransfer factor (TF) prevents genital and/or labial herpes relapses”. Biotherapy, Vol. 9:62-72, 1996.
Page 2 and 3: By Guna ® S.p.a. Scientific Depart
Page 4 and 5: GUNA-TFGUNA-TF MECHANISMOF ACTIONOn
Page 6 and 7: GUNA-TFFOR WHICH DISEASES CANGUNA-T
Page 10 and 11: GUNA-TF CANDIDAGUNA-TF CANDIDACompo
Page 12 and 13: GUNA-TF PAPILLOMAGUNA-TF PAPILLOMAC
Page 14 and 15: GUNA-TFLiterature references1. Blum
Page 16 and 17: Literature referencesLa Medicina Bi

GUNA-TF - Cyto-Solutions Ltd

Create successful ePaper yourself

Delete template?

Save as template?